HEXELECT
LIVE

Serial Number

79253307

Owner

Genmab B.V.

Attorney

Max Vern

Filing Date

Nov 15, 2018

Add to watchlist:

No watchlists yet
View on USPTO

HEXELECT Trademark

Serial Number: 79253307 • Registration: 5952365

HEXELECT is a trademark filed by Genmab B.V. on November 15, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

Genmab B.V. (4 trademarks)

Uppsalalaan 15

Entity Type: 16

Trademark Details

Filing Date

November 15, 2018

Registration Date

January 7, 2020

Published for Opposition

October 22, 2019

Goods & Services

Pharmaceutical and veterinary preparations, namely, pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these for use with regard to the treatment of cancer, infectious, immune, autoimmune, inflammatory, neurodegenerative and cardiovascular diseases

Chemical, biochemical, biological, and biotechnological preparations, namely, antibodies, and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals

Legal services in the field of patent exploitation, namely, patent consultation, patent licensing, and providing information about patent rights; licensing of intellectual property in the field of medicine

Medical, scientific and biological research, namely, research into antibodies and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, monovalent antibodies, and derivatives or conjugates of any of these; chemical analysis; computer programming, namely, programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, and scientific research, development and therapy with antibodies and bi- and multispecific antibodies as well as antibody fragments, monovalent antibodies, and derivatives or conjugates of any of these

Filing History

NEW REPRESENTATIVE AT IB RECEIVED
Apr 24, 2025 NREP
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jan 7, 2025 REM3
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jun 5, 2024 EWAF
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 5, 2024 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 5, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 5, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 5, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 5, 2024 COAR
FINAL DECISION TRANSACTION PROCESSED BY IB
May 8, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Apr 18, 2020 FICS
FINAL DISPOSITION PROCESSED
Apr 18, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 7, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 22, 2019 NPUB
PUBLISHED FOR OPPOSITION
Oct 22, 2019 PUBO
NOTIFICATION PROCESSED BY IB
Oct 19, 2019 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 2, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 2, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 2, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 16, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 13, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 13, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 13, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 13, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 31, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 31, 2019 CRFA
ASSIGNED TO LIE
Aug 31, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 26, 2019 TROA
REFUSAL PROCESSED BY IB
Apr 6, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 20, 2019 RFCS
REFUSAL PROCESSED BY MPU
Mar 20, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 9, 2019 RFCR
APPLICATION FILING RECEIPT MAILED
Mar 9, 2019 MAFR
NON-FINAL ACTION WRITTEN
Mar 8, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 5, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 5, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 28, 2019 REPR